The Telehealth Market in 2026

Telehealth has stabilised at approximately 3–5 times its pre-pandemic adoption level in most developed markets. In the USA, approximately 25% of outpatient visits are now conducted virtually in some form. In Europe, adoption varies widely from the Netherlands and Nordics (high) to Southern and Eastern Europe (lower but growing rapidly). In emerging markets — particularly Southeast Asia, Africa, and the Middle East — telehealth is growing even faster, driven by physician shortages, geographic access challenges, and mobile-first digital adoption. The global telehealth market is projected to reach USD 455 billion by 2030.

Remote Patient Monitoring: The Device Growth Driver

Remote Patient Monitoring (RPM) is the medical device-intensive component of telehealth. RPM involves patients using medical devices at home to collect vital signs and health data that is transmitted to healthcare providers for review and management. Key RPM device categories include: blood pressure monitors with cellular or Bluetooth connectivity, pulse oximeters, weight scales for heart failure management, blood glucose meters and continuous glucose monitors, ECG patches and wearable cardiac monitors, spirometers for COPD management, and temperature and general vital signs hubs. Each of these is a regulated medical device requiring CE marking or FDA clearance. Turkish manufacturers of blood pressure monitors, pulse oximeters, and blood glucose devices are directly positioned in this growth market.

Connected Diagnostic Devices for Teleconsultation

Beyond vital signs monitoring, a growing category of connected diagnostic devices enables clinical-quality examinations to be conducted remotely: digital stethoscopes (3M Littmann, Eko Health) transmit auscultation audio to remote physicians, otoscopes with connected cameras enable ear and throat examination, dermatoscopes with high-resolution imaging enable remote skin assessment, portable ultrasound devices (Butterfly Network, Philips Lumify) enable point-of-care imaging with remote expert review. These devices require both hardware manufacturing capability and software integration with teleconsultation platforms — creating opportunities for Turkish manufacturers with hardware production strengths.

Connectivity Standards and Interoperability

The technical infrastructure of telehealth depends on connectivity standards that device manufacturers must comply with: Bluetooth LE (BLE) for short-range device-to-smartphone communication, HL7 FHIR (Fast Healthcare Interoperability Resources) for health data transmission to EHR systems, Continua Guidelines (IEEE 11073 family) for device-to-gateway interoperability, DICOM for medical imaging data transmission, and GDPR/HIPAA-compliant data security protocols. Turkish medical device manufacturers developing connected RPM devices should prioritise Bluetooth LE + HL7 FHIR compatibility — the two standards that maximise interoperability with major teleconsultation platforms (Doxy.me, Teladoc, Babylon Health) and hospital EHR systems (Epic, Cerner).

Emerging Market Telehealth: The Highest Growth Opportunity

Telehealth growth in emerging markets — Southeast Asia, Africa, the Middle East, and South Asia — is driven by different factors than developed markets: physician shortages and geographic access barriers make telehealth a necessity rather than a convenience. In markets like Nigeria, Indonesia, Kenya, and Bangladesh — all high-priority markets for Turkish medical device exporters — telehealth infrastructure investment is creating strong demand for RPM devices, connected diagnostic tools, and teleconsultation hardware. Turkish manufacturers who build connectivity into their product designs are positioned to serve this emerging market telehealth infrastructure build-out.

Regulatory Classification of Telehealth Devices

Medical devices used in telehealth are regulated under the same frameworks as equivalent non-connected devices — connectivity does not automatically elevate regulatory class. However: any device that transmits data to a healthcare provider for clinical decision-making is typically considered a medical device under both EU MDR and FDA, cybersecurity and data security requirements apply to all connected devices, and cloud-based software components (apps, data aggregation platforms) that perform clinical functions may separately qualify as SaMD requiring regulatory clearance. Turkish manufacturers of connected medical devices must address both the hardware device CE/FDA pathway and the associated software application regulatory status.

Conclusion

Telehealth infrastructure is creating sustained, multi-year demand for the connected medical devices that power it. Turkish manufacturers of vital signs monitoring devices, diagnostic tools, and home care equipment who invest in connectivity compliance — Bluetooth LE, HL7 FHIR, and cybersecurity standards — will be positioned to supply one of the most rapidly growing procurement categories in global healthcare. The technology investment is accessible; the market opportunity is substantial.